Related Experiment Video
Updated: May 20, 2026

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
Oral mucosal decontamination with chlorhexidine for the prevention of ventilator-associated pneumonia in children - a
Meghna Raju Sebastian1, Rakesh Lodha, Arti Kapil
1From the Department of Pediatrics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.
Insights
Oral chlorhexidine gel did not prevent ventilator-associated pneumonia in children. This study found no significant difference in pneumonia rates between chlorhexidine and placebo groups, indicating limited efficacy for this intervention.
Area of Science:
- Pediatric critical care medicine
- Infectious disease prevention
- Pharmacology
Background:
- Ventilator-associated pneumonia (VAP) is a significant complication in pediatric intensive care units.
- Effective strategies for VAP prevention in children are crucial to reduce morbidity and mortality.
Purpose of the Study:
- To evaluate the efficacy of 1% chlorhexidine gel applied to the oral mucosa for preventing ventilator-associated pneumonia in pediatric patients.
- To assess the impact of chlorhexidine decontamination on VAP incidence, duration of hospital/ICU stay, and mortality.
Main Methods:
- A double-blind, randomized, placebo-controlled trial was conducted in a tertiary care pediatric intensive care unit.
- Eighty-six children aged 3 months to 15 years requiring mechanical ventilation received either 1% chlorhexidine or placebo gel applied to the buccal mucosa every 8 hours for up to 21 days.
- VAP diagnosis followed CDC criteria, and outcomes included VAP incidence, ICU/hospital stay duration, and mortality.
Main Results:
- The incidence of VAP was similar between the chlorhexidine (39.6/1,000 ventilator days) and placebo (38.1/1,000 ventilator days) groups (p=0.46).
- No significant differences were observed in the duration of intensive care unit stay, hospital stay, or mortality rates between the groups.
- Gram-negative bacteria, particularly Acinetobacter species, were the most common pathogens isolated; no adverse effects were reported.
Conclusions:
- Topical oral application of 1% chlorhexidine gel did not demonstrate efficacy in preventing ventilator-associated pneumonia in pediatric patients aged 3 months to 15 years.
- Further research may be needed to explore alternative or adjunctive strategies for VAP prevention in this vulnerable population.
Objective:
To study the efficacy of oral mucosal decontamination with chlorhexidine gel for the prevention of ventilator-associated pneumonia in children between 3 months and 15 yrs.
Design:
Double blind randomized placebo controlled trial.
Setting:
Pediatric intensive care unit of a tertiary care hospital in North India.
Patients:
Eligible participants were patients aged 3 months to 15 yrs who required orotracheal or nasotracheal intubation and mechanical ventilation. Two hundred eighty-three children admitted to the pediatric intensive care unit between November 2007 and April 2009 were screened. Eighty-six patients fulfilled the study requirements.
Intervention:
Either 1% chlorhexidine or placebo gel was applied on the buccal mucosa at 8-hr intervals for the entire duration of ventilation, subject to a maximum of 21 days. Patients were followed up for the development of ventilator-associated pneumonia, diagnosed using the Centers for Disease Control and Prevention criteria.
Main Outcome Measures:
Incidence of ventilator-associated pneumonia, duration of hospital stay, duration of intensive care unit stay, mortality, and characteristics of organisms isolated.
Results:
Fourty-one children received 1% chlorhexidine, whereas 45 received placebo application. Patients of both groups were comparable with respect to baseline characteristics. Incidence of ventilator-associated pneumonia was 39.6/1,000 ventilator days with 1% chlorhexidine and 38.1/1,000 ventilator days with placebo (relative risk 1.03, confidence interval 0.44-2.42, p = .46). The duration of intensive care unit stay and hospital stay was a mean of 8.4 ± 5.8 vs. 9.6 ± 11.4 days (p = .58) and 16.1 ± 10.2 days vs. 15.1 ± 14.3 days (p = .19) with chlorhexidine and placebo, respectively. The mortality rates were similar in the two groups (p = .81). All but two isolates causing ventilator-associated pneumonia were gram-negative, with Acinetobacter species being the most common (14 of 26). No side effects of the applied gel were seen in either group.
Conclusion:
Oral mucosal application on 1% chlorhexidine gel did not prevent the development of ventilator-associated pneumonia in children 3 months to 15 yrs age.
Related Concept Videos
Suctioning the Oropharyngeal Airway
After assembling the equipment, the nurse should practice hand hygiene and don appropriate PPE according to infection control guidelines to avoid the...
Hand hygiene
Hand washing...
Suctioning the Nasopharyngeal Airway
Equipment Required
Tracheostomy Decannulation
Description of the Procedure
Decannulation refers to the permanent removal of the tracheostomy tube, signaling the resolution of the condition that initially necessitated the tracheostomy. The process requires a well-coordinated interplay between...
Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen
Venturi Mask
The Venturi mask, named after the Venturi effect, is designed to deliver precise oxygen concentrations. It consists of a large tube with an oxygen inlet that narrows down, causing a pressure drop that pulls air in through adjustable side ports. The mask is a lightweight,...
Tracheostomy Suctioning II: Procedure